Quest Diagnostics 2003 Annual Report Download - page 48

Download and view the complete annual report

Please find page 48 of the 2003 Quest Diagnostics annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 109

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109

10.15 Term Loan Credit Agreement dated as of December 19, 2003 among Quest Diagnostics
Incorporated, certain subsidiary guarantors of the Company, the lenders party thereto, and
Sumitomo Mitsui Banking Corporation
10.16 Stock and Asset Purchase Agreement dated as of February 9, 1999 among SmithKline Beecham
plc, SmithKline Beecham Corporation and the Company (the “Stock and Asset Purchase
Agreement’’) (filed as Appendix A of the Company’s Definitive Proxy Statement dated May 11,
1999 and incorporated herein by reference)
10.17 Amendment No. 1 dated August 6, 1999 to the Stock and Asset Purchase Agreement (filed as an
Exhibit to the Company’s current report on Form 8-K (Date of Report: August 16, 1999) and
incorporated herein by reference)
10.18 Non-Competition Agreement dated as of August 16, 1999 between SmithKline Beecham plc and
the Company (filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report:
August 16, 1999) and incorporated herein by reference)
10.19 Stockholders Agreement dated as of August 16, 1999 between SmithKline Beecham plc and the
Company (filed as an Exhibit to the Company’s current report on Form 8-K (Date of Report:
August 16, 1999) and incorporated herein by reference)
10.20 Amended and Restated Global Clinical Trials Agreement, dated as of December 19, 2002
between SmithKline Beecham plc dba GlaxoSmithKline and the Company (filed as an Exhibit to
post effective amendment No. 1 to the Company’s Registration Statement on Form S-4
(No. 333-88330) and incorporated herein by reference)
10.21 Agreement and Plan of Merger, dated as of April 2, 2002, as amended, among the Company,
Quest Diagnostics Newco Incorporated and Unilab Corporation (filed as an annex to the
Company’s final prospectus, dated August 6, 2002, and incorporated herein by reference)
10.22 Amendment to the Agreement and Plan of Merger, dated as of May 13, 2002, among the
Company, Quest Diagnostics Newco Incorporated and Unilab Corporation (filed as an annex to
the Company’s final prospectus, dated August 6, 2002, and incorporated herein by reference)
10.23 Amendment No. 2 to the Agreement and Plan of Merger, dated as of June 20, 2002, among the
Company, Quest Diagnostics Newco Incorporated and Unilab Corporation (filed as an annex to
the Company’s final prospectus, dated August 6, 2002, and incorporated herein by reference)
10.24 Amendment No. 3 to the Agreement and Plan of Merger, dated as of September 25, 2002,
among the Company, Quest Diagnostics Newco Incorporated and Unilab Corporation (incorporated
herein by reference to Exhibit (a)(11) of the Company’s Schedule TO Amendment No. 12 filed
with the Commission on September 26, 2002, file No. 001-12215)
10.25 Amendment No. 4 to the Agreement and Plan of Merger, dated as of January 4, 2003, among
the Company, Quest Diagnostics Newco Incorporated and Unilab Corporation (incorporated herein
by reference to Exhibit (a)(20) of Quest Diagnostics’ Schedule TO Amendment No. 20 filed with
the Commission on January 6, 2003, file No. 001-12215)
10.26 Form of Employees Stock Purchase Plan, as amended (filed as an Exhibit to the Company’s
annual report on Form 10-K for the year ended December 31, 2002 and incorporated herein by
reference)
10.27 Form of 1996 Employee Equity Participation Program, as amended (filed as an Exhibit to the
Company’s quarterly report on Form 10-Q for the quarter ended September 30, 2002 and
incorporated herein by reference)
10.28 Form of 1999 Employee Equity Participation Program, as amended as of July 31, 2003 (filed as
an Exhibit to the Company’s quarterly report on Form 10-Q for the quarter ended June 30, 2003
and incorporated herein by reference)
10.29 Procedures for the Exercise of Designated Options by Covered Employees (filed as an Exhibit to
the Company’s quarterly report on Form 10-Q for the quarter ended June 30, 2003 and
incorporated herein by reference)
10.30 Form of Stock Option Plan for Non-Employee Directors (filed as an Exhibit to post effective
amendment No. 1 to the Company’s Registration Statement on Form S-4 (No. 333-88330) and
incorporated herein by reference)
10.31 Form of Amended and Restated Deferred Compensation Plan For Directors (filed as an Exhibit to
the Company’s quarterly report on Form 10-Q for the quarter ended June 30, 2003 and
incorporated herein by reference)
31